UnitedHealth Group CEO Andrew Witty will step down from his role at the top of the company due to personal reasons, the healthcare giant announced Tuesday morning. Stephen Hemsley, who previously ...

May 13, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty ...

UnitedHealth Group shares tumbled in early Tuesday trading after the health care giant suspended its 2025 profit outlook and said Andrew Witty would step down as group chief executive ...

Andrew Witty, UnitedHealth Group's CEO, stepped down for personal reasons, the company announced Tuesday. Stephen Hemsley has been appointed the company's CEO. Meanwhile, UnitedHealth Group has ...

May 13 (UPI) --UnitedHealth Group announced Tuesday CEO Andrew Witty will step down, citing "personal reasons." Witty will leave the role of CEO and be replaced by Stephen J. Hemsley, effective ...

Hemsley was UnitedHealth Group CEO from 2006 to 2017. He will remain chairman of the company’s board. Witty will serve as a senior adviser to Hemsley. It has been a punishing period for ...

UnitedHealth Group Chief Executive Officer Andrew Witty stepped down, effective immediately, "for personal reasons", the company said Tuesday. “Leading the people of UnitedHealth Group has been ...

UnitedHealth Group, a key Dow-30 index company with a market capitalization of $284 billion, is down 38% year to date and by a similar margin over the last one year. (Shutterstock) UnitedHealth ...

Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible ...

UnitedHealth Group plans to stop paying commissions next month to brokers and sales agents who sell new Medicare Part D prescription drug plans. The insurer, which has had a rough week that's ...

The UnitedHealth group is under investigation by the US Department of Justice (DOJ) for possible Medicare fraud, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.